Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
Clin Mol Hepatol. 2013 Mar;19(1):17-25. doi: 10.3350/cmh.2013.19.1.17. Epub 2013 Mar 25.
Hepatitis C virus (HCV) is a positive sense, single-stranded RNA virus in the Flaviviridae family. It causes acute hepatitis with a high propensity for chronic infection. Chronic HCV infection can progress to severe liver disease including cirrhosis and hepatocellular carcinoma. In the last decade, our basic understanding of HCV virology and life cycle has advanced greatly with the development of HCV cell culture and replication systems. Our ability to treat HCV infection has also been improved with the combined use of interferon, ribavirin and small molecule inhibitors of the virally encoded NS3/4A protease, although better therapeutic options are needed with greater antiviral efficacy and less toxicity. In this article, we review various aspects of HCV life cycle including viral attachment, entry, fusion, viral RNA translation, posttranslational processing, HCV replication, viral assembly and release. Each of these steps provides potential targets for novel antiviral therapeutics to cure HCV infection and prevent the adverse consequences of progressive liver disease.
丙型肝炎病毒(HCV)是黄病毒科正链单股 RNA 病毒。它可引起高倾向于慢性感染的急性肝炎。慢性 HCV 感染可进展为严重肝脏疾病,包括肝硬化和肝细胞癌。在过去十年中,随着 HCV 细胞培养和复制系统的发展,我们对 HCV 病毒学和生命周期的基本认识有了很大的提高。随着干扰素、利巴韦林和病毒编码的 NS3/4A 蛋白酶小分子抑制剂的联合使用,我们治疗 HCV 感染的能力也得到了提高,尽管需要更好的治疗方案,以提高抗病毒疗效和降低毒性。在本文中,我们回顾了 HCV 生命周期的各个方面,包括病毒附着、进入、融合、病毒 RNA 翻译、翻译后加工、HCV 复制、病毒组装和释放。这些步骤中的每一步都为新型抗病毒治疗提供了潜在的靶点,以治愈 HCV 感染并防止进行性肝脏疾病的不良后果。